data_1io6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1io6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.468 ' HA3' ' ND2' ' A' ' 58' ' ' ASN . . . . . . . . 1 N--CA 1.529 4.848 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 4' ' ' TYR . 34.6 m -122.55 118.42 28.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -1.184 . . . . 0.0 109.528 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.669 ' O ' ' CD1' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -45.68 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.436 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.669 ' CD1' ' O ' ' A' ' 3' ' ' THR . 11.9 m-85 -155.19 179.45 9.14 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.854 0.835 . . . . 0.0 110.347 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.594 ' CG2' ' HB ' ' A' ' 27' ' ' ILE . 24.1 m -151.37 -145.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.617 ' HG2' ' CD1' ' A' ' 26' ' ' PHE . 13.4 mt-30 -167.29 118.58 0.89 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . . . -60.11 98.24 0.06 Allowed 'General case' 0 C--N 1.288 -2.075 0 O-C-N 121.351 -0.843 . . . . 0.0 111.485 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.578 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 1.5 mt -57.82 -25.4 60.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 8' ' ' LEU . 28.9 m-85 -141.23 133.21 27.65 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.523 ' HA ' ' N ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -46.22 136.38 7.05 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 21' ' ' PHE . 84.3 t80 -114.6 155.56 26.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.957 -1.09 . . . . 0.0 110.522 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.573 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -131.94 152.78 80.87 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -74.83 121.47 6.66 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 122.512 2.142 . . . . 0.0 110.525 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.0 -26.22 13.48 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.586 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -113.39 -146.91 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 108.91 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.56 86.91 2.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.903 -1.123 . . . . 0.0 109.592 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.01 -1.18 5.0 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' OE1' ' HB2' ' A' ' 48' ' ' MET . 4.2 mm-40 -72.44 143.68 48.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.2 . . . . 0.0 109.237 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 41' ' ' ALA . 12.4 tp -56.84 147.75 22.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.197 -0.939 . . . . 0.0 109.732 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.94 124.59 5.07 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 11' ' ' PHE . 2.6 p90 -153.81 -174.35 4.92 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.194 -1.18 . . . . 0.0 110.285 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.549 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -137.2 153.86 50.33 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.549 ' O ' ' HD2' ' A' ' 22' ' ' ARG . 9.7 ttp180 -38.07 125.37 1.24 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.224 -0.922 . . . . 0.0 111.677 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.71 -4.51 53.59 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.565 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . 9.9 m-20 -79.99 115.9 19.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.127 -1.219 . . . . 0.0 108.675 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.617 ' CD1' ' HG2' ' A' ' 6' ' ' GLN . 3.3 m-85 -71.77 106.34 4.1 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.343 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.594 ' HB ' ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.59 118.66 23.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.233 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 4' ' ' TYR . 3.8 t-160 -73.23 80.1 1.31 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.526 ' CG2' HG13 ' A' ' 5' ' ' VAL . 21.8 t -41.1 103.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.601 ' CB ' ' HA2' ' A' ' 40' ' ' GLY . 8.0 tpp -96.31 -20.27 18.63 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.859 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 39' ' ' LYS . 3.0 t0 -160.09 88.81 0.83 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.143 -0.973 . . . . 0.0 108.953 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.584 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 12.1 p-10 -85.19 32.42 0.55 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 110.076 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.14 -9.29 58.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.994 -1.066 . . . . 0.0 109.106 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.58 ' OD1' ' CD2' ' B' ' 3' ' ' TYR . 1.2 t0 -100.65 146.86 32.79 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.364 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HD2' ' CG ' ' A' ' 34' ' ' ASP . 36.1 Cg_endo -79.23 -21.88 8.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.747 2.298 . . . . 0.0 111.354 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -134.96 -8.56 2.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.847 -1.158 . . . . 0.0 110.904 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.615 ' CZ3' ' HD3' ' A' ' 50' ' ' PRO . 48.8 m95 -135.42 99.81 4.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.832 -1.167 . . . . 0.0 109.352 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.626 ' CZ3' ' HB2' ' A' ' 51' ' ' ARG . 43.0 m0 -88.92 127.58 35.65 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.066 -1.021 . . . . 0.0 109.552 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' A' ' 30' ' ' MET . 0.0 OUTLIER -75.18 101.13 4.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.601 ' HA2' ' CB ' ' A' ' 30' ' ' MET . . . -143.84 -167.15 11.67 Favored Glycine 0 C--N 1.274 -2.9 0 C-N-CA 118.271 -1.918 . . . . 0.0 113.047 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 27' ' ' ILE . . . -114.06 -167.24 1.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 27' ' ' ILE . 1.2 p -158.92 -52.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.403 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -159.76 47.98 0.28 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.675 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.9 -22.44 11.57 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.5 ' O ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.85 155.27 26.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -1.182 . . . . 0.0 109.408 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.555 ' HB ' ' NZ ' ' A' ' 39' ' ' LYS . 12.0 p -133.58 173.86 11.05 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.417 -0.802 . . . . 0.0 109.21 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' O ' ' HE3' ' A' ' 39' ' ' LYS . . . 150.12 -155.64 26.34 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.539 ' SD ' ' CG ' ' A' ' 39' ' ' LYS . 21.7 mmm -101.56 130.67 47.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.069 -1.254 . . . . 0.0 110.353 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.606 ' CE2' ' CG1' ' A' ' 54' ' ' VAL . 3.2 p90 -138.43 152.52 71.39 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.615 ' HD3' ' CZ3' ' A' ' 37' ' ' TRP . 31.0 Cg_endo -71.92 117.06 4.96 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 121.276 1.317 . . . . 0.0 110.099 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.626 ' HB2' ' CZ3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -53.51 -19.16 3.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.533 -0.729 . . . . 0.0 109.928 -179.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.474 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.5 t-20 -78.64 -35.04 45.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.972 -1.08 . . . . 0.0 110.074 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.506 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 2.4 m-85 -59.89 -12.74 8.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.986 -1.071 . . . . 0.0 108.638 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.606 ' CG1' ' CE2' ' A' ' 49' ' ' PHE . 5.3 m -125.41 179.02 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 122.411 1.101 . . . . 0.0 110.282 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -139.0 143.91 39.01 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.46 ' HA ' HG12 ' A' ' 5' ' ' VAL . 28.2 Cg_endo -68.88 133.77 28.11 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.13 1.887 . . . . 0.0 110.793 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.2 OUTLIER -107.69 174.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 57' ' ' VAL . 4.6 t30 77.57 139.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.838 . . . . 0.0 109.354 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.52 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -129.99 47.07 2.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.35 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 16.7 m-85 -56.91 -27.17 60.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' B' ' 3' ' ' TYR . 0.0 OUTLIER 73.58 145.82 0.11 Allowed Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.207 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.557 ' HD2' ' HG3' ' B' ' 4' ' ' ARG . 30.8 Cg_endo -73.0 120.67 6.75 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.394 2.062 . . . . 0.0 109.888 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.54 HD21 ' CB ' ' A' ' 50' ' ' PRO . 0.8 OUTLIER -33.34 121.85 0.45 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 122.061 -0.399 . . . . 0.0 110.512 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.512 ' HD2' ' CD2' ' B' ' 6' ' ' LEU . 33.2 Cg_endo -75.59 163.27 34.34 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.242 1.962 . . . . 0.0 109.974 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.38 126.27 9.62 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.959 2.44 . . . . 0.0 111.365 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.38 154.39 94.5 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.882 . . . . 0.0 109.26 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' CD2' ' A' ' 9' ' ' PHE . 34.8 Cg_endo . . . . . 0 C--N 1.305 -1.761 0 C-N-CA 122.899 2.399 . . . . 0.0 110.624 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . . . . . . 1 N--CA 1.529 4.848 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 4' ' ' TYR . 34.6 m -122.55 118.42 28.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -1.184 . . . . 0.0 109.528 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.69 HG22 ' HB ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -45.68 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.436 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.669 ' CD1' ' O ' ' A' ' 3' ' ' THR . 11.9 m-85 -155.19 179.45 9.14 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.854 0.835 . . . . 0.0 110.347 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.657 ' CG2' ' HB ' ' A' ' 27' ' ' ILE . 24.1 m -151.37 -145.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.642 ' HG2' ' CD1' ' A' ' 26' ' ' PHE . 13.4 mt-30 -167.29 118.58 0.89 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -60.11 98.24 0.06 Allowed 'General case' 0 C--N 1.288 -2.075 0 O-C-N 121.351 -0.843 . . . . 0.0 111.485 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 55' ' ' THR . 1.5 mt -57.82 -25.4 60.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.794 ' HD2' HD22 ' B' ' 9' ' ' LEU . 28.9 m-85 -141.23 133.21 27.65 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -46.22 136.38 7.05 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 21' ' ' PHE . 84.3 t80 -114.6 155.56 26.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.957 -1.09 . . . . 0.0 110.522 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.573 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -131.94 152.78 80.87 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -74.83 121.47 6.66 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 122.512 2.142 . . . . 0.0 110.525 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.0 -26.22 13.48 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.586 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -113.39 -146.91 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 108.91 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.56 86.91 2.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.903 -1.123 . . . . 0.0 109.592 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.01 -1.18 5.0 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' A' ' 48' ' ' MET . 4.2 mm-40 -72.44 143.68 48.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.2 . . . . 0.0 109.237 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD21 ' C ' ' A' ' 41' ' ' ALA . 12.4 tp -56.84 147.75 22.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.197 -0.939 . . . . 0.0 109.732 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.94 124.59 5.07 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 11' ' ' PHE . 2.6 p90 -153.81 -174.35 4.92 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.194 -1.18 . . . . 0.0 110.285 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -137.2 153.86 50.33 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.57 ' O ' ' HD2' ' A' ' 22' ' ' ARG . 9.7 ttp180 -38.07 125.37 1.24 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.224 -0.922 . . . . 0.0 111.677 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.71 -4.51 53.59 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.594 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . 9.9 m-20 -79.99 115.9 19.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.127 -1.219 . . . . 0.0 108.675 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CD1' ' HG2' ' A' ' 6' ' ' GLN . 3.3 m-85 -71.77 106.34 4.1 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.343 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.915 HG21 ' CE1' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -76.59 118.66 23.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.233 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 1.061 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.8 t-160 -73.23 80.1 1.31 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.69 ' HB ' HG22 ' A' ' 3' ' ' THR . 21.8 t -41.1 103.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.607 ' CB ' ' HA2' ' A' ' 40' ' ' GLY . 8.0 tpp -96.31 -20.27 18.63 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.859 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' CB ' ' HB3' ' A' ' 39' ' ' LYS . 3.0 t0 -160.09 88.81 0.83 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.143 -0.973 . . . . 0.0 108.953 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.589 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 12.1 p-10 -85.19 32.42 0.55 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 110.076 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.14 -9.29 58.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.994 -1.066 . . . . 0.0 109.106 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.58 ' OD1' ' CD2' ' B' ' 3' ' ' TYR . 1.2 t0 -100.65 146.86 32.79 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.364 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 34' ' ' ASP . 36.1 Cg_endo -79.23 -21.88 8.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.747 2.298 . . . . 0.0 111.354 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -134.96 -8.56 2.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.847 -1.158 . . . . 0.0 110.904 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.608 ' CZ3' ' HD3' ' A' ' 50' ' ' PRO . 48.8 m95 -135.42 99.81 4.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.832 -1.167 . . . . 0.0 109.352 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.654 ' CE3' ' HB2' ' A' ' 51' ' ' ARG . 43.0 m0 -88.92 127.58 35.65 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.066 -1.021 . . . . 0.0 109.552 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.58 ' NZ ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.18 101.13 4.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.607 ' HA2' ' CB ' ' A' ' 30' ' ' MET . . . -143.84 -167.15 11.67 Favored Glycine 0 C--N 1.274 -2.9 0 C-N-CA 118.271 -1.918 . . . . 0.0 113.047 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 1.061 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . . . -114.06 -167.24 1.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 19' ' ' LEU . 1.2 p -158.92 -52.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.403 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -159.76 47.98 0.28 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.675 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.9 -22.44 11.57 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.527 ' O ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.85 155.27 26.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -1.182 . . . . 0.0 109.408 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.9 HG22 ' HB2' ' A' ' 41' ' ' ALA . 12.0 p -133.58 173.86 11.05 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.417 -0.802 . . . . 0.0 109.21 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.472 ' O ' ' HE3' ' A' ' 39' ' ' LYS . . . 150.12 -155.64 26.34 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.672 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 21.7 mmm -101.56 130.67 47.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.069 -1.254 . . . . 0.0 110.353 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.915 ' CE1' HG21 ' A' ' 27' ' ' ILE . 3.2 p90 -138.43 152.52 71.39 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.608 ' HD3' ' CZ3' ' A' ' 37' ' ' TRP . 31.0 Cg_endo -71.92 117.06 4.96 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 121.276 1.317 . . . . 0.0 110.099 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.654 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -53.51 -19.16 3.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.533 -0.729 . . . . 0.0 109.928 -179.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 8' ' ' LEU . 3.5 t-20 -78.64 -35.04 45.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.972 -1.08 . . . . 0.0 110.074 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.5 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 2.4 m-85 -59.89 -12.74 8.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.986 -1.071 . . . . 0.0 108.638 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 ' CG1' ' CE2' ' A' ' 49' ' ' PHE . 5.3 m -125.41 179.02 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 122.411 1.101 . . . . 0.0 110.282 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.666 HG22 ' HG ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -139.0 143.91 39.01 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 5' ' ' VAL . 28.2 Cg_endo -68.88 133.77 28.11 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.13 1.887 . . . . 0.0 110.793 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -107.69 174.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 57' ' ' VAL . 4.6 t30 77.57 139.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.838 . . . . 0.0 109.354 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' NH1' ' HG2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.52 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -129.99 47.07 2.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.35 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 16.7 m-85 -56.91 -27.17 60.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.56 ' HG3' ' HD2' ' B' ' 5' ' ' PRO . 0.0 OUTLIER 73.58 145.82 0.11 Allowed Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.207 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' B' ' 4' ' ' ARG . 30.8 Cg_endo -73.0 120.67 6.75 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.394 2.062 . . . . 0.0 109.888 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 1.045 HD23 ' HD2' ' B' ' 7' ' ' PRO . 0.8 OUTLIER -33.34 121.85 0.45 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 122.061 -0.399 . . . . 0.0 110.512 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 1.045 ' HD2' HD23 ' B' ' 6' ' ' LEU . 33.2 Cg_endo -75.59 163.27 34.34 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.242 1.962 . . . . 0.0 109.974 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.38 126.27 9.62 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.959 2.44 . . . . 0.0 111.365 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.794 HD22 ' HD2' ' A' ' 9' ' ' PHE . 94.7 mt -70.38 154.39 94.5 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.882 . . . . 0.0 109.26 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PRO . . . . . 0.417 ' HD2' ' CD2' ' A' ' 9' ' ' PHE . 34.8 Cg_endo . . . . . 0 C--N 1.305 -1.761 0 C-N-CA 122.899 2.399 . . . . 0.0 110.624 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . . . . . . 1 N--CA 1.529 4.848 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 4' ' ' TYR . 34.6 m -122.55 118.42 28.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -1.184 . . . . 0.0 109.528 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.69 HG22 ' HB ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -45.68 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.436 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.669 ' CD1' ' O ' ' A' ' 3' ' ' THR . 11.9 m-85 -155.19 179.45 9.14 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 121.854 0.835 . . . . 0.0 110.347 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.657 ' CG2' ' HB ' ' A' ' 27' ' ' ILE . 24.1 m -151.37 -145.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.642 ' HG2' ' CD1' ' A' ' 26' ' ' PHE . 13.4 mt-30 -167.29 118.58 0.89 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . . . -60.11 98.24 0.06 Allowed 'General case' 0 C--N 1.288 -2.075 0 O-C-N 121.351 -0.843 . . . . 0.0 111.485 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.666 ' HG ' HG22 ' A' ' 55' ' ' THR . 1.5 mt -57.82 -25.4 60.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.794 ' HD2' HD22 ' B' ' 9' ' ' LEU . 28.9 m-85 -141.23 133.21 27.65 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -46.22 136.38 7.05 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 21' ' ' PHE . 84.3 t80 -114.6 155.56 26.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.957 -1.09 . . . . 0.0 110.522 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.573 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -131.94 152.78 80.87 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -74.83 121.47 6.66 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 122.512 2.142 . . . . 0.0 110.525 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.0 -26.22 13.48 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.586 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -113.39 -146.91 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 108.91 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.56 86.91 2.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.903 -1.123 . . . . 0.0 109.592 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.01 -1.18 5.0 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' A' ' 48' ' ' MET . 4.2 mm-40 -72.44 143.68 48.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.2 . . . . 0.0 109.237 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.835 HD21 ' C ' ' A' ' 41' ' ' ALA . 12.4 tp -56.84 147.75 22.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.197 -0.939 . . . . 0.0 109.732 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.94 124.59 5.07 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 11' ' ' PHE . 2.6 p90 -153.81 -174.35 4.92 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.194 -1.18 . . . . 0.0 110.285 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -137.2 153.86 50.33 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.57 ' O ' ' HD2' ' A' ' 22' ' ' ARG . 9.7 ttp180 -38.07 125.37 1.24 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.224 -0.922 . . . . 0.0 111.677 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.71 -4.51 53.59 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.594 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . 9.9 m-20 -79.99 115.9 19.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.127 -1.219 . . . . 0.0 108.675 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CD1' ' HG2' ' A' ' 6' ' ' GLN . 3.3 m-85 -71.77 106.34 4.1 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.343 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.915 HG21 ' CE1' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -76.59 118.66 23.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.233 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 1.061 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 3.8 t-160 -73.23 80.1 1.31 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.69 ' HB ' HG22 ' A' ' 3' ' ' THR . 21.8 t -41.1 103.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.607 ' CB ' ' HA2' ' A' ' 40' ' ' GLY . 8.0 tpp -96.31 -20.27 18.63 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.859 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' CB ' ' HB3' ' A' ' 39' ' ' LYS . 3.0 t0 -160.09 88.81 0.83 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.143 -0.973 . . . . 0.0 108.953 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.589 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 12.1 p-10 -85.19 32.42 0.55 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 110.076 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.14 -9.29 58.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.994 -1.066 . . . . 0.0 109.106 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.58 ' OD1' ' CD2' ' B' ' 3' ' ' TYR . 1.2 t0 -100.65 146.86 32.79 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.364 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 34' ' ' ASP . 36.1 Cg_endo -79.23 -21.88 8.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.747 2.298 . . . . 0.0 111.354 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -134.96 -8.56 2.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.847 -1.158 . . . . 0.0 110.904 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.608 ' CZ3' ' HD3' ' A' ' 50' ' ' PRO . 48.8 m95 -135.42 99.81 4.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.832 -1.167 . . . . 0.0 109.352 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.654 ' CE3' ' HB2' ' A' ' 51' ' ' ARG . 43.0 m0 -88.92 127.58 35.65 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.066 -1.021 . . . . 0.0 109.552 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.58 ' NZ ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.18 101.13 4.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.607 ' HA2' ' CB ' ' A' ' 30' ' ' MET . . . -143.84 -167.15 11.67 Favored Glycine 0 C--N 1.274 -2.9 0 C-N-CA 118.271 -1.918 . . . . 0.0 113.047 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 1.061 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . . . -114.06 -167.24 1.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 19' ' ' LEU . 1.2 p -158.92 -52.87 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.403 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -159.76 47.98 0.28 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 109.675 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.9 -22.44 11.57 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.527 ' O ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.85 155.27 26.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -1.182 . . . . 0.0 109.408 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.9 HG22 ' HB2' ' A' ' 41' ' ' ALA . 12.0 p -133.58 173.86 11.05 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.417 -0.802 . . . . 0.0 109.21 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.472 ' O ' ' HE3' ' A' ' 39' ' ' LYS . . . 150.12 -155.64 26.34 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.672 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 21.7 mmm -101.56 130.67 47.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.069 -1.254 . . . . 0.0 110.353 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.915 ' CE1' HG21 ' A' ' 27' ' ' ILE . 3.2 p90 -138.43 152.52 71.39 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.608 ' HD3' ' CZ3' ' A' ' 37' ' ' TRP . 31.0 Cg_endo -71.92 117.06 4.96 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 121.276 1.317 . . . . 0.0 110.099 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.654 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -53.51 -19.16 3.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.533 -0.729 . . . . 0.0 109.928 -179.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 8' ' ' LEU . 3.5 t-20 -78.64 -35.04 45.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.972 -1.08 . . . . 0.0 110.074 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.5 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 2.4 m-85 -59.89 -12.74 8.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.986 -1.071 . . . . 0.0 108.638 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 ' CG1' ' CE2' ' A' ' 49' ' ' PHE . 5.3 m -125.41 179.02 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 122.411 1.101 . . . . 0.0 110.282 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.666 HG22 ' HG ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -139.0 143.91 39.01 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 5' ' ' VAL . 28.2 Cg_endo -68.88 133.77 28.11 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.13 1.887 . . . . 0.0 110.793 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.602 HG23 ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -107.69 174.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 57' ' ' VAL . 4.6 t30 77.57 139.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.36 -0.838 . . . . 0.0 109.354 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' NH1' ' HG2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.52 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -129.99 47.07 2.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.35 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 16.7 m-85 -56.91 -27.17 60.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.38 -0.825 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.56 ' HG3' ' HD2' ' B' ' 5' ' ' PRO . 0.0 OUTLIER 73.58 145.82 0.11 Allowed Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.207 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' B' ' 4' ' ' ARG . 30.8 Cg_endo -73.0 120.67 6.75 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.394 2.062 . . . . 0.0 109.888 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 1.045 HD23 ' HD2' ' B' ' 7' ' ' PRO . 0.8 OUTLIER -33.34 121.85 0.45 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 122.061 -0.399 . . . . 0.0 110.512 -179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 1.045 ' HD2' HD23 ' B' ' 6' ' ' LEU . 33.2 Cg_endo -75.59 163.27 34.34 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.242 1.962 . . . . 0.0 109.974 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.38 126.27 9.62 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.959 2.44 . . . . 0.0 111.365 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.794 HD22 ' HD2' ' A' ' 9' ' ' PHE . 94.7 mt -70.38 154.39 94.5 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.882 . . . . 0.0 109.26 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . 0.417 ' HD2' ' CD2' ' A' ' 9' ' ' PHE . 34.8 Cg_endo . . . . . 0 C--N 1.305 -1.761 0 C-N-CA 122.899 2.399 . . . . 0.0 110.624 -179.859 . . . . . . . . 1 1 . 1 stop_ save_